Hui Liao

674 total citations
32 papers, 495 citations indexed

About

Hui Liao is a scholar working on Molecular Biology, Nephrology and Organic Chemistry. According to data from OpenAlex, Hui Liao has authored 32 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Nephrology and 7 papers in Organic Chemistry. Recurrent topics in Hui Liao's work include Gout, Hyperuricemia, Uric Acid (8 papers), Radioactive element chemistry and processing (4 papers) and Case Reports on Hematomas (3 papers). Hui Liao is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (8 papers), Radioactive element chemistry and processing (4 papers) and Case Reports on Hematomas (3 papers). Hui Liao collaborates with scholars based in China, United States and Egypt. Hui Liao's co-authors include Xuegang Luo, Jian Zhou, Xiaoyan Lin, Dehua Pei, Qiuhua Zhu, Wenfeng Li, Tao Duan, Yongde Zhang, Meng Kuang and Jie Yu and has published in prestigious journals such as Journal of Hazardous Materials, ACS Applied Materials & Interfaces and Applied Surface Science.

In The Last Decade

Hui Liao

31 papers receiving 491 citations

Peers

Countries citing papers authored by Hui Liao

Since Specialization

Citations

This map shows the geographic impact of Hui Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Liao more than expected).

Fields of papers citing papers by Hui Liao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Liao. The network helps show where Hui Liao may publish in the future.

Co-authorship network of co-authors of Hui Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Liao. A scholar is included among the top collaborators of Hui Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Liao. Hui Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of digallic acid as XOD/URAT1 dual target inhibitor for the treatment of hyperuricemia 2024 ·Bioorganic Chemistry ·(unknown), (unknown), (unknown), (unknown), Wenjie Ye, (unknown), (unknown), (unknown), Zitao Guo, Shuqin Zhang, Hui Liao, Ting Wu, Yuanxin Tian, Qun Zhang, Jianxin Pang, Zean Zhao	10
2	Proline-derived quinoline formamide compounds as human urate transporter 1 inhibitors with potent uric acid-lowering activities 2024 ·European Journal of Medicinal Chemistry ·Shengnan Li, Hui Liao, (unknown), (unknown), (unknown), Sheng Li, Hongyi Zhao, Yi Huan, Lei Lei, (unknown), (unknown), (unknown), Ting Wu, Gang Li, Jianxin Pang, Haihong Huang	2
3	Salinomycin, a potent inhibitor of XOD and URAT1, ameliorates hyperuricemic nephropathy by activating NRF2, modulating the gut microbiota, and promoting SCFA production 2024 ·Chemico-Biological Interactions ·Yongjun Chen, Zitao Guo, (unknown), (unknown), (unknown), (unknown), (unknown), Wenjie Ye, (unknown), (unknown), Ning Li, (unknown), Hui Liao, Ting Wu, Jianxin Pang	9
4	Pharmacological evaluation of a novel skeleton compound isobavachin (4′,7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1/GLUT9 and xanthine oxidase inhibitory activity 2023 ·Bioorganic Chemistry ·Zean Zhao, Jian Luo, Hui Liao, (unknown), Xinhua Chen, Jiajun Luo, Yongjun Chen, (unknown), Shuqin Zhang, (unknown), Ting Wu, Yongmei Li, Lu Li, Yang Yang, (unknown), Qun Zhang, Yuanxin Tian, Jianxin Pang	22
5	Mutation in Transmembrane Domain 8 of Human Urate Transporter 1 Disrupts Uric Acid Recognition and Transport 2022 ·ACS Omega ·(unknown), Zean Zhao, Hui Liao, (unknown), Yongjun Chen, Ting Wu, Yuanxin Tian, Jianxin Pang	7
6	Discovery of novel benzbromarone analogs with improved pharmacokinetics and benign toxicity profiles as antihyperuricemic agents 2022 ·European Journal of Medicinal Chemistry ·Zean Zhao, Jin Liu, L. Yuan, Zichao Yang, (unknown), Hui Liao, Jian Luo, (unknown), (unknown), Yongjun Chen, Ting Wu, Jiayin Guo, Ying Cao, Yang� Yang, (unknown), Qun Zhang, Jianjun Chen, Jianxin Pang	14
7	Design, synthesis and structure-activity relationship of dihydrobenzoquinolines as novel inhibitors against influenza A virus 2022 ·European Journal of Medicinal Chemistry ·Hui Liao, Yinyan Li, (unknown), (unknown), Jie Yang, Qiuhua Zhu	1
8	Through-bond/space conjugated nonaromatic dihydrobenzoquinolines: Luminogens with simple synthesis method, strong aggregation-induced emission and emissive excimers 2022 ·Dyes and Pigments ·(unknown), Hui Liao, (unknown), Wenjing Li, Qiuhua Zhu	4
9	Risk factors of regional lymph node (RLN) metastasis among patients with bone sarcoma and survival of patients with RLN-positive bone sarcoma 2021 ·Annals of Translational Medicine ·Yimin Dong, Wei Wu, Honglei Kang, Wei Xiong, Dawei Ye, Zhong Fang, Hanfeng Guan, Hui Liao, Feng Li	12
10	Discovery of novel quinazoline-based covalent inhibitors of KRAS G12C with various cysteine-targeting warheads as potential anticancer agents 2021 ·Bioorganic Chemistry ·Ling Li, (unknown), Hui Liao, (unknown), (unknown), Jin Liu, (unknown), (unknown)	16
11	Hydrothermal synthesis of honey/bayberry microsphere for uranium removal from aqueous solution 2021 ·Journal of Radioanalytical and Nuclear Chemistry ·Hui Zhu, Jian Zhou, (unknown), Hui Liao, (unknown), W. Ding	2
12	Rational design of cell-permeable cyclic peptides containing a d-Pro-l-Pro motif 2020 ·Bioorganic & Medicinal Chemistry ·(unknown), Hui Liao, (unknown), (unknown), Ziqing Qian, Chunhua Yuan, Mark P. Foster, Dehua Pei	9
13	Discovery of dihydropyrrolidones as novel inhibitors against influenza A virus 2020 ·European Journal of Medicinal Chemistry ·Teng Liu, Chenshu Dai, (unknown), (unknown), (unknown), Hui Liao, Shuwen Liu, Qiuhua Zhu, Jie Yang	10
14	[A non-coated enzyme-linked immunosorbent assay for screening zika virus envelope protein]. 2019 ·PubMed ·(unknown), Weifeng Zhou, Hui Liao, Zhengyang Hu, Min Zou, Shuwen Liu	1
15	Marinobacter sp. Stable Hydrous Titanium Oxide-Functionalized Bovine Serum Albumin Nanospheres for Uranium Capture from Spiked Seawater 2019 ·ACS Applied Materials & Interfaces ·Jie Yu, Hui Liao, Wenkun Zhu, Tao Duan, Shanlin Wang, Meng Kuang, Yongde Zhang, Xiaoyan Lin, Xuegang Luo, Jian Zhou	32
16	Water–DMSO-promoted one-pot synthesis of two new series of dihydropyrrolo[2,3-h]quinolines 2019 ·Organic & Biomolecular Chemistry ·Hui Liao, Qiuhua Zhu	13
17	New zonal structure and transition of the membrane to mammillae in the eggshell of chicken Gallus domesticus 2018 ·Journal of Structural Biology ·Yunong Li, Yang Li, Shirong Liu, Yang Tang, Bing Mo, Hui Liao	14
18	Methylenetetrahydrofolate dehydrogenase 2 overexpression is associated with tumor aggressiveness and poor prognosis in hepatocellular carcinoma 2016 ·Digestive and Liver Disease ·Xincheng Liu, Yu Huang, (unknown), Huohui Ou, (unknown), Hui Liao, Xianghong Li, Dinghua Yang	41
19	HMGA2 induces epithelial-to-mesenchymal transition in human hepatocellular carcinoma cells 2013 ·Oncology Letters ·(unknown), Wenfeng Li, Hui Liao	32
20	Ni<sub>2</sub>P Catalysts Supported on TiO<sub>2</sub>-Pillared Sepiolite for Thiophene Hydrodesulfurization 2012 ·Acta Physico-Chimica Sinica ·Hui Liao, (unknown), (unknown), Weiqing Chen, (unknown), Wenming Liu, Xiang Wang, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact